Daniel Carvajal‐Hausdorf

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer

Joseph McLaughlin, Gang Han, Kurt A. Schalper et al. · JAMA Oncology · 2015 · 839 citations · Full text

Medicine, Immunology, Oncology +17

Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer

Kurt A. Schalper, Jason R. Brown, Daniel Carvajal‐Hausdorf et al. · JNCI Journal of the National Cancer Institute · 2015 · 431 citations · Full text

Medicine, Immunology, Oncology +17

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer

Kurt A. Schalper, Daniel Carvajal‐Hausdorf, Joseph McLaughlin et al. · Clinical Cancer Research · 2016 · 206 citations · Full text

Medicine, Oncology, Pathology +17

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

Daniel Carvajal‐Hausdorf, Mehmet Altan, Vamsidhar Velcheti et al. · Journal for ImmunoTherapy of Cancer · 2019 · 203 citations · Full text

Life Sciences, Immunology, Oncology +17

Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer

Jamaal Rehman, Gang Han, Daniel Carvajal‐Hausdorf et al. · Modern Pathology · 2016 · 166 citations · Full text

Medicine, Cancer Biology, Oncology +10